Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CPL207280 in Type 2 Diabetes
NCT05248776Phase 2Unknown
- Sponsor
- Celon Pharma S.A.
- Start
- Jan 2022
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CPL207280 in type 2 diabetes mellitus (T2DM), sponsored by Celon Pharma S.A.. Status: unknown.
02
Drugs
CPL207280
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT05248776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05248776.